SCHEMBL23830003

SCHEMBL23830003

Cc1ccccc1/C=C/C(=O)c1ccc(O)cc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 5/20 0.60
ABCG2 Q9UNQ0 1/20 0.56
NR1H4 Q96RI1 2/20 0.56
BACE1 P56817 1/20 0.54
TYR P14679 1/20 0.53
NFE2L2 Q16236 1/20 0.52
CAPN1 P07384 2/20 0.51
CTSL P07711 2/20 0.51
CTSB P07858 2/20 0.51
KDM4E B2RXH2 3/20 0.50
MEN1 O00255 3/20 0.50
MAPT P10636 3/20 0.50
KMT2A Q03164 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP3A4 P08684 1/20 0.50
THRB P10828 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23830004 1.00 CHRNA7 (0.60) CHRNA7ABCG2NR1H4BACE1TYR
SCHEMBL17975272 0.90 CHRNA7 (0.76) CHRNA7ABCG2NR1H4BACE1TYR
SCHEMBL4865615 0.84 BCHE (0.56) CHRNA7NR1H4NFE2L2KDM4EMEN1
SCHEMBL29018468 0.83 MAPT (0.67) CHRNA7ABCG2TYRCAPN1CTSL
SCHEMBL9629524 0.81 MEN1 (0.48) CHRNA7ABCG2NR1H4KDM4EMEN1
SCHEMBL9629519 0.81 MEN1 (0.48) CHRNA7ABCG2NR1H4KDM4EMEN1
SCHEMBL31398696 0.81 CHRNA7 (0.76) CHRNA7ABCG2NR1H4BACE1TYR
SCHEMBL31398711 0.81 CHRNA7 (0.76) CHRNA7ABCG2NR1H4BACE1TYR
SCHEMBL675698 0.80 BCHE (0.75) CHRNA7KDM4EMEN1MAPTKMT2A
SCHEMBL8101054 0.80 BCHE (0.75) CHRNA7KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292265-A1 CHALCONES AND DERIVATIVES FOR USE IN MEDICAMENTS AND NUTRACEUTICALS HLXTH B.V. (NL) 2021-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210292265-A1 CHALCONES AND DERIVATIVES FOR USE IN MEDICAMENTS AND NUTRACEUTICALS IL1B, IL1A, IL1R1 CHRNA7 3383/4885ABCG2 4093/4885NR1H4 1310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.